FoodTrendFinder.com
Share
Wellness

Mycoprotein Whole Cuts Challenge the Meat Case

Next-generation fermentation technology is delivering the 'fibrous tear' that soy and pea proteins couldn't achieve, reshaping the $150B protein category.

By FTW Editorial·June 18, 2026·5 min read
An overhead cinematic shot of a diverse group of adults in a bright, modern open-plan kitchen, laughing and sharing a meal featuring sliced grilled fillets, fresh greens, and artisanal bread.

The plant-based sector is undergoing a massive shift as 3D-structured mycoprotein whole cuts move from niche labs to mainstream retail. Led by innovators like MycoForge and PrimeFilament, these 'fungi-steaks' are capturing the flexitarian market by offering the fibrous texture and clean labels that early soy-based analogs lacked.

What happened

In May 2026, the category leader MycoForge debuted its 'PrimeFilament' line—the first commercially viable mycoprotein ribeye and chicken breast using advanced 3D-hyphae scaffolding. Simultaneously, FungiTech Global announced a strategic partnership with the supermarket giant Nationwide Grocers to replace 15% of their private-label plant-based SKU count with textured mycoprotein whole cuts by year-end 2026. This shift marks the end of the 'Extrusion Era.' Unlike traditional plant-based meats that rely on high-moisture extrusion to force protein into shapes, these new whole cuts are 'grown' into their final form using precision fermentation and acoustic-assisted molding. In the first two weeks of June 2026, unit sales for mycoprotein cuts surpassed those of legacy soy-protein burgers in three major metropolitan test markets (Seattle, Austin, and London), signaling a permanent shift in consumer preference toward more sophisticated meat mimics.

Why it matters

This is more than a trend; it is a technological correction of the plant-based sector's previous failings. The 'Plant-Based 1.0' era suffered from a lack of culinary versatility—you could make a burger, but you couldn't make a roast or a tender scallopini. Mycoprotein’s naturally occurring filamentous structure allows for a 'whole-muscle' mouthfeel that mimics the connective tissue of animal proteins. This allows it to penetrate the high-margin 'center of the plate' dinner segment that has remained stubbornly dominated by animal agriculture. Furthermore, the environmental and efficiency data is becoming too large for institutional investors to ignore. As of mid-2026, mycoprotein production uses 90% less land and 75% less water than bovine protein, but more importantly, it offers a 2:1 conversion ratio from feedstock to edible protein. As traditional livestock prices face volatility due to 2025’s carbon-tax implementations in the EU and North America, mycoprotein whole cuts provide a stable-price hedge for food service providers and industrial kitchens.

Market impact

The global mycoprotein whole-cut segment has seen a Year-over-Year (YoY) growth of 34% as of Q2 2026, significantly outperforming the stagnant 2.1% growth in traditional extruded plant-based crumbles. Financial analysts at CapitalGrove project the mycoprotein market to reach $4.8 billion by 2028, driven by lower CAPEX requirements compared to cultivated lab-grown meat. In June 2026, MycoForge secured a $210 million Series C funding round to expand its 'Micro-Filament' fermentation facility in Ohio, aiming to bring the price per pound down to $5.40—narrowing the gap with organic poultry. Retailers like EverGreen Markets report that when mycoprotein steaks are placed in the "integrated meat aisle" rather than the specialty vegan section, sales velocity increases by nearly 50%.

Consumer insight

Recent tracking by ConsumerPulse IQ indicates a "texture threshold" breakthrough in 2026. While early adopters accepted mushy patties, 64% of flexitarians now cite "fibrous resistance"—the physical sensation of tearing through muscle fiber—as their primary requirement for repeat purchases. Mycoprotein whole cuts are successfully bridging this gap, with 41% of survey respondents unable to distinguish between a seasoned MycoForge cutlet and a standard chicken breast in blind taste tests. Furthermore, the "clean label" movement has evolved into the "short label" demand. Consumers are migrating away from ultra-processed plant-based products with 20+ ingredients. Because mycoprotein naturally possesses a meat-like structure through its hyphae filaments, it requires 40% fewer binding agents (like methylcellulose) than soy or pea analogs, appealing to the health-conscious 'Pro-Metabolic' demographic.

Strategic takeaway

Operators and retailers must pivot their merchandising strategies to treat mycoprotein not as a 'vegetarian substitute' but as a premium, sustainable protein tier. Investing in private-label whole-cut fungi proteins now will capture the lucrative 'High-Fiber Flexitarian' segment. As production costs decline through 2026, the competitive advantage will shift to brands that emphasize culinary versatility and 'short-label' transparency over purely ethical marketing.
#mycoprotein#food-technology#alternative-protein#fermentation#retail-strategy#clean-label#sustainability#market-analysis

Get the next signal in your inbox.

Daily food industry intelligence — free.

More signals